Elena B Elkin

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi Changes in access to screening mammography, 2008-2011
    Elena B Elkin
    Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Cancer Causes Control 24:1057-9. 2013
  2. ncbi The economic impact of a patient navigator program to increase screening colonoscopy
    Elena B Elkin
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer 118:5982-8. 2012
  3. ncbi Mammography capacity and appointment wait times: barriers to breast cancer screening
    Elena B Elkin
    Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 44, New York, NY 10021, USA
    Cancer Causes Control 23:45-50. 2012
  4. ncbi Economic evaluation of targeted cancer interventions: critical review and recommendations
    Elena B Elkin
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    Genet Med 13:853-60. 2011
  5. ncbi Geographic access and the use of screening mammography
    Elena B Elkin
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Med Care 48:349-56. 2010
  6. ncbi HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis
    Elena B Elkin
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 44, New York, NY 10021, USA
    J Clin Oncol 22:854-63. 2004
  7. ncbi Disenrollment from Medicare managed care among beneficiaries with and without a cancer diagnosis
    Elena B Elkin
    Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 44, New York, NY 10021, USA
    J Natl Cancer Inst 100:1013-21. 2008
  8. ncbi Desire for information and involvement in treatment decisions: elderly cancer patients' preferences and their physicians' perceptions
    Elena B Elkin
    Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 44, New York, NY 10021, USA
    J Clin Oncol 25:5275-80. 2007
  9. ncbi Primer: using decision analysis to improve clinical decision making in urology
    Elena B Elkin
    Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Nat Clin Pract Urol 3:439-48. 2006
  10. ncbi The effect of changes in tumor size on breast carcinoma survival in the U.S.: 1975-1999
    Elena B Elkin
    Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Cancer 104:1149-57. 2005

Detail Information

Publications39

  1. ncbi Changes in access to screening mammography, 2008-2011
    Elena B Elkin
    Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Cancer Causes Control 24:1057-9. 2013
    ..Provisions of the federal healthcare reform law that eliminate cost sharing for selected preventive health services may improve access to screening mammography and prevent further declines in the rate of breast cancer screening...
  2. ncbi The economic impact of a patient navigator program to increase screening colonoscopy
    Elena B Elkin
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer 118:5982-8. 2012
    ..Patient navigation can increase colorectal cancer screening rates. The net economic impact of a colonoscopy patient navigator program was evaluated in an urban public hospital setting...
  3. ncbi Mammography capacity and appointment wait times: barriers to breast cancer screening
    Elena B Elkin
    Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 44, New York, NY 10021, USA
    Cancer Causes Control 23:45-50. 2012
    ..To assess the impact of mammography capacity on appointment wait times...
  4. ncbi Economic evaluation of targeted cancer interventions: critical review and recommendations
    Elena B Elkin
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    Genet Med 13:853-60. 2011
    ....
  5. ncbi Geographic access and the use of screening mammography
    Elena B Elkin
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
    Med Care 48:349-56. 2010
    ..Inadequate mammography resources in some areas may impair access to this technology. We assessed the relationship between availability of mammography machines and the use of screening...
  6. ncbi HER-2 testing and trastuzumab therapy for metastatic breast cancer: a cost-effectiveness analysis
    Elena B Elkin
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 44, New York, NY 10021, USA
    J Clin Oncol 22:854-63. 2004
    ..Several tests of varying accuracy and cost are available to identify candidates for trastuzumab. We estimated the cost-effectiveness of alternative HER-2 testing and trastuzumab treatment strategies...
  7. ncbi Disenrollment from Medicare managed care among beneficiaries with and without a cancer diagnosis
    Elena B Elkin
    Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 44, New York, NY 10021, USA
    J Natl Cancer Inst 100:1013-21. 2008
    ..We compared rates of voluntary disenrollment from Medicare managed care to traditional fee-for-service Medicare among Medicare managed care enrollees with and without a cancer diagnosis...
  8. ncbi Desire for information and involvement in treatment decisions: elderly cancer patients' preferences and their physicians' perceptions
    Elena B Elkin
    Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 44, New York, NY 10021, USA
    J Clin Oncol 25:5275-80. 2007
    ..Shared decision making is a tenet of contemporary medicine and oncology practice. How involved elderly patients want to be in making treatment decisions and how physicians perceive patient preferences for such involvement are uncertain...
  9. ncbi Primer: using decision analysis to improve clinical decision making in urology
    Elena B Elkin
    Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Nat Clin Pract Urol 3:439-48. 2006
    ..Greater incorporation of decision-analytic techniques into urology research and clinical practice might improve decision making, and thereby improve patient outcomes...
  10. ncbi The effect of changes in tumor size on breast carcinoma survival in the U.S.: 1975-1999
    Elena B Elkin
    Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    Cancer 104:1149-57. 2005
    ..The objective of the current study was to characterize within-stage migration of tumor size in breast carcinoma, and to estimate the effect of this shift on reported breast carcinoma survival...
  11. ncbi Adjuvant ovarian suppression versus chemotherapy for premenopausal, hormone-responsive breast cancer: quality of life and efficacy tradeoffs
    Elena B Elkin
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, Box 44, New York, NY 10021, USA
    Breast Cancer Res Treat 93:25-34. 2005
    ..We used a decision-analytic framework to evaluate tradeoffs between efficacy and quality of life in the choice between these treatments...
  12. ncbi Adjuvant chemotherapy and survival in older women with hormone receptor-negative breast cancer: assessing outcome in a population-based, observational cohort
    Elena B Elkin
    Health Outcomes Research Group and Biostatistics Service, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    J Clin Oncol 24:2757-64. 2006
    ..Our goal was to assess the relationship between adjuvant chemotherapy use and survival in a large, population-based cohort of older women with hormone receptor (HR) -negative breast cancer...
  13. ncbi Patterns of treatment in older adults with primary central nervous system lymphoma
    Katherine S Panageas
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer 110:1338-44. 2007
    ..The objective of the current study was to identify factors associated with the receipt and type of treatment in a population-based cohort of older PCNSL patients...
  14. ncbi Physician visits prior to treatment for clinically localized prostate cancer
    Thomas L Jang
    Department of Surgery, Sidney Kimmel Center for Prostate and Urologic Cancers, New York, New York, USA
    Arch Intern Med 170:440-50. 2010
    ..We evaluated how visits to specialists and primary care physicians (PCPs) by men with localized prostate cancer are related to treatment choice...
  15. ncbi Temporal trends and predictors of pelvic lymph node dissection in open or minimally invasive radical prostatectomy
    Andrew H Feifer
    Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA
    Cancer 117:3933-42. 2011
    ..The objectives of this study were to identify predictors of PLND and to assess the impact of surgical technique in a contemporary, population-based cohort...
  16. ncbi Androgen deprivation and thromboembolic events in men with prostate cancer
    Behfar Ehdaie
    Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Cancer 118:3397-406. 2012
    ..The objective of this study was to estimate the impact of ADT on thromboembolic events (TEs) in a population-based cohort...
  17. ncbi Extensions to decision curve analysis, a novel method for evaluating diagnostic tests, prediction models and molecular markers
    Andrew J Vickers
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, 307 East 63rd Street, New York, NY 10065, USA
    BMC Med Inform Decis Mak 8:53. 2008
    ..Most critically, decision curve analysis can be applied directly to a data set, and does not require the sort of external data on costs, benefits and preferences typically required by traditional decision analytic techniques...
  18. ncbi Staging laparoscopy in the management of gastric cancer: a population-based analysis
    Paul J Karanicolas
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    J Am Coll Surg 213:644-651, 651.e1. 2011
    ..We sought to assess the use of staging laparoscopy for gastric adenocarcinoma in a cohort of older patients and to compare outcomes after laparoscopy alone with nontherapeutic laparotomy...
  19. ncbi Prognosis and patterns of care in elderly patients with glioma
    Fabio M Iwamoto
    Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Cancer 115:5534-40. 2009
    ..The current study was conducted to evaluate the patterns of care and survival of older adults with oligodendroglioma (OLI) and astrocytoma (AST) from a large population-based registry...
  20. ncbi Costs of medical care after open or minimally invasive prostate cancer surgery: a population-based analysis
    William T Lowrance
    Division of Urology, Department of Surgery, Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah 84112, USA
    Cancer 118:3079-86. 2012
    ..MRP with robotic assistance is generally more expensive than ORP, but it is not clear whether subsequent costs of care vary by approach...
  21. ncbi Cost-effectiveness of fracture prevention in men who receive androgen deprivation therapy for localized prostate cancer
    Kouta Ito
    Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Ann Intern Med 152:621-9. 2010
    ..Objective: To assess the cost-effectiveness of measuring bone mineral density (BMD) before initiating ADT followed by alendronate therapy in men with localized prostate cancer...
  22. ncbi Decision curve analysis: a novel method for evaluating prediction models
    Andrew J Vickers
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, USA
    Med Decis Making 26:565-74. 2006
    ....
  23. ncbi Treatment for patients with rectal cancer and a clinical complete response to neoadjuvant therapy: a decision analysis
    Heather B Neuman
    Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
    Dis Colon Rectum 52:863-71. 2009
    ..Therefore, the objective was to develop a decision-analytic model to evaluate the relative benefits of surgery vs. observation in rectal cancer patients who achieve clinical complete response after neoadjuvant chemoradiation...
  24. ncbi Long-term health outcomes of a decision aid: data from a randomized trial of adjuvant! In women with localized breast cancer
    Andrew J Vickers
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, USA
    Med Decis Making 29:461-7. 2009
    ..The authors aimed to model the effects of the Adjuvant! decision aid on expected survival in women with early stage breast cancer. PATIENTS and..
  25. ncbi The impact of race and comorbidity on survival in endometrial cancer
    Sara H Olson
    Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Cancer Epidemiol Biomarkers Prev 21:753-60. 2012
    ..The aims of this study were to determine whether diabetes, hypertension, or other conditions influence survival and whether accounting for these conditions reduces this racial disparity...
  26. ncbi Patterns of care in elderly glioblastoma patients
    Fabio M Iwamoto
    Department of Neurology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Ann Neurol 64:628-34. 2008
    ..To evaluate the patterns of care in elderly glioblastoma (GBM) patients from a large population-based registry...
  27. ncbi Benchmarking lung cancer mortality rates in current and former smokers
    Peter B Bach
    Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 221, New York, NY 10021, USA
    Chest 126:1742-9. 2004
    ..The model is intended for use in analyzing a population of subjects who are undergoing lung cancer screening or receiving lung cancer chemoprevention, to determine whether the intervention has altered lung cancer mortality...
  28. ncbi Costs and trends in pancreatic cancer treatment
    Caitriona B O'Neill
    Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    Cancer 118:5132-9. 2012
    ....
  29. ncbi Radiation therapy facilities in the United States
    Leslie K Ballas
    The Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
    Int J Radiat Oncol Biol Phys 66:1204-11. 2006
    ....
  30. ncbi Preference assessment method affects decision-analytic recommendations: a prostate cancer treatment example
    Elena B Elkin
    Department of Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
    Med Decis Making 24:504-10. 2004
    ..If decision analysis is used to counsel individual patients, careful consideration must be given to the method of preference elicitation...
  31. ncbi Comparative effectiveness of prostate cancer surgical treatments: a population based analysis of postoperative outcomes
    William T Lowrance
    Urology Service, Department of Surgery, Sidney Kimmel Center for Prostate and Urologic Cancers, and Health Outcomes Research Group, New York, New York, USA
    J Urol 183:1366-72. 2010
    ..We compared laparoscopic prostatectomy with or without robotic assistance vs open radical prostatectomy in terms of postoperative outcomes and subsequent cancer directed therapy...
  32. ncbi The future of mammography: radiology residents' experiences, attitudes, and opinions
    Shrujal S Baxi
    Health Outcomes Research Group, Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
    AJR Am J Roentgenol 194:1680-6. 2010
    ..The objective of our study was to assess the experiences and preferences of radiology residents with respect to breast imaging...
  33. ncbi Lessons learned from 416 cases of nipple discharge of the breast
    Mary Morrogh
    Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, USA
    Am J Surg 200:73-80. 2010
    ..For patients with nipple discharge (ND), surgical duct excision is often required to exclude underlying malignancy. Our objective was to define clinical predictors of malignancy and examine the utility of common preoperative studies...
  34. ncbi Trends in the use of incontinence procedures after radical prostatectomy: a population based analysis
    Philip H Kim
    Urology Service, Department of Surgery, Sidney Kimmel Center for Prostate and Urologic Cancers, New York, New York 10065, USA
    J Urol 189:602-8. 2013
    ..Urinary incontinence is a frequent complication of radical prostatectomy with a detrimental impact on quality of life. We identified predictors and trends in the use of procedures for post-prostatectomy incontinence...
  35. ncbi Breast imaging fellowships in the United States: who, what, and where?
    Shrujal S Baxi
    Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
    AJR Am J Roentgenol 192:403-7. 2009
    ..CONCLUSION: A comprehensive list of fellowship training opportunities in breast imaging may help potential applicants identify relevant programs...
  36. ncbi Characteristics and outcomes of breast cancer in women with and without a history of radiation for Hodgkin's lymphoma: a multi-institutional, matched cohort study
    Elena B Elkin
    Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA
    J Clin Oncol 29:2466-73. 2011
    ..To compare characteristics and outcomes of breast cancer in women with and without a history of radiation therapy (RT) for Hodgkin's lymphoma (HL)...
  37. ncbi Trends in survival from primary central nervous system lymphoma, 1975-1999: a population-based analysis
    Katherine S Panageas
    Department of Epidemiology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
    Cancer 104:2466-72. 2005
    ..Although results from clinical trials suggest progress in the treatment of PCNSL, survival improvements are not reflected in this population-based cohort...
  38. ncbi Treatment patterns and prognosis in patients with human immunodeficiency virus and primary central system lymphoma
    Teri N Kreisl
    Neuro Oncology Branch, National Cancer Institute, Bethesda, MD 20892, USA
    Leuk Lymphoma 49:1710-6. 2008
    ..028). Despite improved treatment for both diseases over the past decade, survival remains dismal in this cohort of Medicare/Medicaid beneficiaries with HIV-related PCNSL. These results may not apply to the general HIV population...
  39. ncbi Should older women have antepartum testing to prevent unexplained stillbirth?
    Ruth C Fretts
    Harvard Medical Associates, Brigham and Women s Hospital and Harvard Medical School, Boston, Massachusetts, USA
    Obstet Gynecol 104:56-64. 2004
    ..We compared usual care (no antepartum testing or induction before 41 weeks), weekly testing at 37 weeks with induction after a positive test, and no testing with induction at 41 weeks...